Fig. 6

Clinical characteristics and immune correlation analysis of the cuproptosis score model. (A) Immune infiltration correlation analysis network; (B) Representative image of HE staining from the TCGA database showing the immune cell infiltration in the two high-score cuproptosis groups from TCGA; (C) Immunotherapy efficacy score in the two groups. (*P < 0.05; ** P < 0.01; and *** P < 0.001; Ns, not significant). TCGA, The Cancer Genome Atlas; HE, hematoxylin and eosin